A major limitation to understanding the etiopathogenesis of environmental enteric dysfunction (EED) is the lack of a comprehensive, reproducible histologic framework for characterizing the small bowel lesions. We hypothesized that the development of such a system will identify unique histology features for EED, and that some features might correlate with clinical severity.
Duodenal endoscopic biopsies from two cohorts where EED is prevalent (Pakistan, Zambia) and North American children with and without gluten sensitive enteropathy (GSE) were processed for routine hematoxylin & eosin (H&E) staining, and scanned to produce whole slide images (WSIs) which we shared among study pathologists via a secure web browser-based platform. A semi-quantitative scoring index composed of 11 parameters encompassing tissue injury and response patterns commonly observed in routine clinical practice was constructed by three gastrointestinal pathologists, with input from EED experts. The pathologists then read the WSIs using the EED histology index, and inter-observer reliability was assessed. The histology index was further used to identify within- and between-child variations as well as features common across and unique to each cohort, and those that correlated with host phenotype.
Eight of the 11 histologic scoring parameters showed useful degrees of variation. The overall concordance across all parameters was 96% weighted agreement, kappa 0.70, and Gwet’s AC 0.93. Zambian and Pakistani tissues shared some histologic features with GSE, but most features were distinct, particularly abundance of intraepithelial lymphocytes in the Pakistani cohort, and marked villous destruction and loss of secretory cell lineages in the Zambian cohort.
We propose the first EED histology index for interpreting duodenal biopsies. This index should be useful in future clinical and translational studies of this widespread, poorly understood, and highly consequential disorder, which might be caused by multiple contributing processes, in different regions of the world.
The study of EED has been limited by the lack of a rigorously tested, reproducible histology index that can provide insight to the pathogenesis of this entity. In this study we report the first duodenal histology index that was developed using an unbiased approach, with excellent inter-observer reproducibility, for the study of EED. The EED histology index readily identified histologic features that are common or unique to cohorts of distinct geographic locations. Incorporating the histology index into future clinical studies will provide useful insight into the pathogenesis and for intervention strategy development.
Citation: Liu T-C, VanBuskirk K, Ali SA, Kelly MP, Holtz LR, Yilmaz OH, et al. (2020) A novel histological index for evaluation of environmental enteric dysfunction identifies geographic-specific features of enteropathy among children with suboptimal growth. PLoS Negl Trop Dis 14(1): e0007975. https://doi.org/10.1371/journal.pntd.0007975
Editor: Margaret Kosek, The Johns Hopkins University, UNITED STATES
Received: August 7, 2019; Accepted: December 6, 2019; Published: January 13, 2020
Copyright: © 2020 Liu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant analyses are within the manuscript and its Supporting Information files. Primary data (whole slide images) will be made available upon request, as the WSIs are housed in WuPax which is also used as a platform for clinical use. Unrestricted access may cause server to function suboptimally and jeopardize clinical work flow. We do intend to grant access to all request for data, but prefer to be in a controlled fashion so as not to interfere with our clinical work flow. Interested parties can contact data access guarantor Jared Amann-Stewart at email@example.com.
Funding: The Pakistan, Zambia, and St. Louis studies were funded by the Bill and Melinda Gates Foundation as independent and distinct research grants (OPP 1144149, 1066200, 1066118, and OPP 1066153, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: I have read the journal's policy and the authors of this manuscript have the following competing interests: Dr. Phillip Tarr is a consultant for Takeda Pharmaceuticals and the Bill & Melinda Gates Foundation. Dr. Phillip Tarr is also a consultant, member of the Scientific Advisory Board, holder of equity, and a co-inventor on a patent that might earn royalties for MediBeacon Inc. The remainder of the authors have declared that no competing interests exist.
Undernutrition remains ubiquitous in low- and middle-income countries (LMICs) and underlies over 40% of child deaths . Wasting, an indicator of acute malnutrition, and defined as weight-for-height standard deviation z score (WHZ) <-2, afflicts 7.3% of children under age five . Severe acute malnutrition (SAM) is defined as WHZ <-3, mid-upper arm circumference <11.5 cm among 6-59-month olds, or the presence of nutritionally-induced bilateral pitting edema. This latter condition is also known as kwashiorkor [3, 4]. Poor linear growth is a reflection of chronic undernutrition. Stunting, defined as height-for-age z score (HAZ) <-2, is used to indicate the prevalence of the problem at the population level. Stunting is associated with increased risk of mortality and developmental delay among children and non-communicable diseases and reduced human capacity into adulthood . An estimated 22% or 150 million children younger than 5 years of age are stunted .
Even the most optimal food-based interventions have limited effects on preventing or correcting linear growth deficits [5–8]. Recently, attention has been directed towards environmental enteric dysfunction (EED) as an important component to suboptimal childhood growth, in particular, poor linear growth [9–13]. EED is an underdiagnosed, highly prevalent condition among children in LMICs [14–18]. EED has been variably termed tropical enteropathy or environmental enteropathy, and was first described as an acquired malabsorption syndrome among adult westerners residing in LMICs [19–21]. A common histologic feature is small intestinal villous blunting, but its etiology remains elusive . The working hypothesis is that an environmental driver, including recurrent or persistent enteric infection, infections from specific pathogen(s), an abundance of nonpathogenic fecal microbes, or distortion of intestinal microbiota composition, could precipitate and/or perpetuate the small bowel response. This process is analogous to the small bowel response to gluten in gluten-sensitive enteropathy (GSE), also known as celiac disease [9, 11, 23].
After a flurry of biopsy studies four decades ago [24–28], there has been a paucity of histologic studies of the small bowel until recently. However, markers in blood, stool, and urine (e.g., urine dual sugar permeability testing) have lent credence to the concept that poor growth and EED are tightly linked in children in LMICs [14, 29–32]. Nonetheless, the origin and pathophysiology of EED remains elusive. This knowledge gap is in part attributable to the limited understanding of the histologic changes associated with this disorder and how they compare to other enteropathies including GSE, which shares features of an environmental trigger and villous blunting on histology . While GSE has not been identified as a prevalent disorder in sub-Saharan Africa and South Asia (outside of India), enteropathy has been identified among children with SAM, especially kwashiorkor, in these settings [34–38].
Based on existing data from cohort studies in diverse populations [14–18], we hypothesized that a histology index using an unbiased approach will allow identification of histopathologic features unique to EED as well as those shared with other enteropathies, and/or identify histologically-identifiable subsets of EED. Here we present the first EED histology index, agnostically constructed and encompassing tissue injury and response patterns commonly observed in clinical practice, in an attempt to improve our understanding of the histopathology underlying this entity or entities. We also describe the rigorous testing used to assess its reproducibility, by applying the scoring index to two distinct cohorts with suboptimal growth recruited from distinct geographic locations where EED is prevalent and North American GSE and control cohorts.
Endoscopic duodenal biopsies from four cohorts were analyzed: (1) Hospitalized 6–36 month olds with SAM and persistent diarrhea in Lusaka, Zambia ; (2) children 18–22 months with non-edematous wasting not requiring hospitalization recruited from a community-based birth cohort in rural Pakistan, and undergoing endoscopy if unresponsive to 2 months of outpatient nutritional intervention ; (3) children <18 years with clinically suspected GSE; and (4) children <18 years with normal tissue transglutaminase (tTG) IgA concentrations, no known inflammatory bowel disorders or prior GSE diagnosis, and in whom a diagnostic upper endoscopy was indicated (Table 1). The latter two groups underwent endoscopy as part of routine clinical care at the Washington University School of Medicine/St. Louis Children's Hospital (St. Louis, Missouri). Exclusion criteria for Zambian and Pakistani cohorts consisted of neurologic, cardiac, congenital, or other conditions associated with failure to thrive; diagnosis with GSE based on elevated tTG IgA concentrations as also an exclusion criteria for the purposes of this EED histopathology scoring index initiative. Children were excluded from the GSE cohort if they had known inflammatory intestinal disorders or a prior history of GSE.
Anthropometric, clinical and laboratory assessments
The following information were collected across all four cohorts: age, sex, recumbent length (children <two years of age), standing height (> two years of age), weight, and history of diarrhea. For convenience, henceforth we refer to both length and height as height. Clinical laboratory testing across all cohorts included hemoglobin, mean corpuscular volume (MCV), C-reactive protein (CRP), and tTG IgA concentrations were determined. tTG IgA assay normal limits differ depending assay kit; we expressed anti-tTG concentrations as percentages of upper limits of normal for the particular kit utilized (IBL International, Germany in Pakistan, Orgentech, Germany in Zambia, Inova, California, and Quest and Labcorp in St. Louis). Additionally, biomarkers potentially reflective of EED or undernutrition processes common to at least two sites’ cohorts were analyzed in this report and included urinary dual sugar (lactulose, rhamnose or lactulose, mannitol) permeability testing (Zambia and St. Louis), and serum concentrations of insulin-like growth factor 1 (IGF-1) and glucagon-like peptide 2 (GLP-2) (Zambia and Pakistan). Individual data are included in S1 Dataset.
Duodenal endoscopic biopsy
In the Pakistan cohort, two to three biopsies from the second portion of the duodenum were taken and each biopsy was embedded in an individual paraffin block. In Zambia, typically three biopsies were collected from the second part of the duodenum for each patient. In the St. Louis site, children with suspected GSE had four biopsies taken from the second portion of the duodenum and two from the bulb, while control children had 2 biopsies from the second portion of the duodenum, per that site’s clinical protocol . No adverse events were noted during or after the procedure. In Zambia and St. Louis, all biopsies from the same child were embedded in a single paraffin block. In Zambia, all biopsies were collected and oriented under a microscope within 10 minutes before fixation. No additional orientation step was taken before fixation for Pakistani, GSE, and control biopsies.
Digital pathology workflow
Whole slide images (WSI) were scanned at 20x magnification from hematoxylin & eosin (H&E) stained slides. The slides from the Pakistan cohort were scanned at Aga Khan University using an Olympus VS120 (Tokyo, Japan) scanner. The slides from the Zambian and St. Louis sites were scanned using an Aperio Scanscope CS scanner at the Washington University Department of Pathology. All WSIs were uploaded to the Washington University Digital Pathology Exchange (WUPax) picture archiving and communication system, a secure browser-based platform developed in 2015 by the Washington University Department of Pathology to meet clinical needs of geographically separated institutions. WUPax is in routine clinical use in a College of American Pathologists (CAP)-accredited, Clinical Laboratory Improvement Act (CLIA)-licensed, and Health Insurance Portability and Accountability Act of 1996 (HIPAA)-compliant environment [43, 44], and has also been adapted for research purposes.
EED scoring index histology criteria
The EED scoring index was developed by three gastrointestinal pathologists (T.C.L., O.Y., C.A.M.), with input from EED experts who are members of the EED Biopsy Initiative Consortium. This system was developed using a hypothesis-free approach by which common and potential features of small intestinal injury patterns were all included, and scored using semi-quantitative categorical measures). The three pathologists accessed the WSIs within WUPax. The features included in the scoring index, the definitions of these features, and the scoring options were refined through a series of four iterative reads of subsets of WSIs from the four cohorts. The process also included identifying parameters that merited efforts for improved inter-observer concordance (see Statistical analysis section below). Following these processes, the complete set of WSIs was scored by the three pathologists using the final histology index, and inter-observer concordance was determined. During each set of reads, the pathologists recorded their scores independently and were blinded to cohort identity and each other’s scores. A histology atlas was developed (C.A.M.) as a guide for applying the scoring index can be accessed at S1 Atlas.
The pathologists scored each WSI as a subjective average across tissue fragments within that WSI. Because the biopsies for the same individual in Zambia and St. Louis were embedded in a single paraffin block, they were therefore processed into a single H&E slide and WSI. However, in Pakistan each biopsy was placed into a single paraffin block, multiple slides and WSIs were available for individual children, enabling us to assess intra-individual score variability between biopsies for this cohort.
Inter-observer agreement was assessed using multiple weighted estimates: percent agreement, kappa, and Gwet’s agreement coefficient (AC). Spearman rank correlation was additionally used to assess correlation between pathologists on total histology score, a summed measure of histologic parameters. Statistical differences in histologic parameter scores between cohorts were assessed using the non-parametric Kruskal-Wallis test, appropriate for ordinal dependent variables, followed by Dunn's multiple comparisons test with Benjamini-Hochberg adjustment within tests, with the false discovery rate (FDR) set at 0.05; we did not adjust for FDR across analyses of different histologic score parameters.
Total histologic score percent was utilized in analyses instead of total histologic score to facilitate comparison across images. While the summed total histologic score would be affected by parameters marked as 'not scorable', converting the score into a percent of total possible points (excluding points for non-scorable parameters) eliminates that issue.
Heterogeneity of total histology scores within and between children in the Pakistani cohort, where each WSI represented single biopsies, was analyzed using a cross-sectional mixed effects model with biopsies nested within each child. The intra-correlation coefficient was used to estimate and compare variances. Averages of scores for individual children were calculated across WSIs for comparative analyses with the other cohorts and relationships with patient characteristics so as not to over-represent one cohort.
Sample sizes were insufficient to conduct hypothesis-driven assessments between histopathology and patient characteristics; however, we did assess for associations as an exploratory analysis. Completeness of anthropometry, but not laboratory, data allowed for cohort-specific assessments of relationship to histology. HAZ, WHZ, body mass index z scores (BMIZ), and weight-for-age z scores (WAZ) were calculated based on World Health Organization (WHO) reference standards , using WHO Anthro (version 3.2.2)  and WHO Anthro Plus software (version 1.0.4) . Per WHO standards, WAZ was calculated only for children under 10 years of age, and BMI and BMIZ were calculated only for children over age 5 . Relationships between histologic scores and cross-sectional patient characteristics—anthropometrics, clinical parameters (history of diarrhea, HIV infection status), and laboratory markers—were assessed by linear regression with histologic scores treated as continuous predictors after assessment by Akaike information criterion (AIC) and Bayesian information criterion (BIC) in comparison with models using the categorical predictors. Models were adjusted for cohort. We did not adjust for multiple comparisons across regressions because of the exploratory nature of this analysis. Where variation in scores for a histologic parameter was minimal (i.e. representing <2 ordinal levels, with ordinal scoring parameters having either 4 or 5 response levels), we did not assess for a relationship. P-values were two-tailed, and alpha was defined as 0.05.
Statistical analyses were performed using Stata v. 15.0 (StataCorp, College Station, TX) and GraphPad Prism 7.0 (GraphPad Software, San Diego, CA).
Institutional approval was granted by the Aga Khan University Ethical Review Committee (2446-Ped-ERC-13), University of Zambia Biomedical Research Ethics Committee (006-01-13)), and Washington University School of Medicine Human Research Protection Office (201505051). Written consent was obtained from parents for all participants.
Demographics and clinical parameters
The demographics of the four cohorts are described in Table 2. The 16 children in the Zambian cohort, by study inclusion criteria, were younger (median age 16.5 months) than the Pakistani cohort (median age 22 months). The Zambian children were also, by inclusion criteria, more severely malnourished (e.g., 44% of the Zambian cohort had a WAZ <-4 compared to 10% of the Pakistani cohort) and all had a recent history of diarrhea. Anemia (median hemoglobin 8.4 grams/deciliter [g/dl] and 9.6 g/dl, respectively) and microcytosis (median MCV 70.1 femtoliter [fL] and 62.0 fL, respectively) were common in both cohorts. The Pakistani children and St. Louis controls had CRP circulating concentrations within normal ranges while 31% of Zambian and 22% of the St. Louis GSE cohort had elevated CRP circulating concentrations. Median tTG IgA concentrations as a percent of the upper limit of normal were 5.8% and 5.2% in the Zambian and Pakistani cohorts, respectively.
The St. Louis cohorts (13 GSE and 6 control participants) were older: median age 9.5 and 11.7 years, respectively. One child in each of the St. Louis cohorts had a BMIZ score <-2, and one child in the GSE cohort had both weight-for-age z score (WAZ) and HAZ <-2. All controls had WAZ and HAZ >-2. No GSE participants had a recent history of diarrhea, compared to 33% of controls. The median tTG IgA concentration was 6.8x and 18% of the normal limit for the GSE and control cohorts, respectively. Hemoglobin concentrations were normal among the controls while one child with GSE (representing 10% of GSE children with hemoglobin data) had a hemoglobin <11 g/dl. MCV ranges in both cohorts were normal.
Anthropometric, clinical, and laboratory parameters between the two LMIC study cohorts did not statistically significantly vary except that, per inclusion criteria, the Zambian cohort were younger, had diarrhea of longer duration, and lower WHZ score (S1A–S1C Fig). There was no significant difference in hemoglobin across the cohorts (S1D Fig) and tTG IgA also did not differ between these groups (S1E Fig).
High inter-observer reproducibility using EED histology scoring index
The histology scoring index assigns a 4–5 tier categorical value to each of the 11 histopathological parameters representing various injury response mechanisms (Table 3). Features with 4-tier grading include: acute (neutrophilic) inflammation, chronic inflammation, eosinophil infiltration, intramucosal Brunner glands, foveolar cell (gastric mucin cell) metaplasia, Paneth cell density, and enterocyte injury. Features with 5-tier grading include: intraepithelial lymphocytes (IELs), villous architecture, goblet cell density, and epithelial detachment. In addition, a total histologic score is calculated as a sum of the individual parameters, and ranges from 0 to 37. Because individual parameters could potentially be deemed “not determinable” because of slide preparation or other quality issues, we also calculated another summative score as a percentage (total histologic score percent), to account for instances where the denominator was <37.
There was good agreement across the three pathologists using the final histology index to score the WSIs (Table 4). Chronic inflammation, IELs and villous architecture shared the lowest percent agreement between pathologists (S2A and S2B Fig). Concordance of total histology percent score was 84.0% weighted agreement, kappa 0.41, and Gwet's AC 0.55, and Spearman's correlations for pathologist pairs ranged from 0.58 to 0.74 (S1 Table). The overall concordance across all parameters was 96% weighted agreement, kappa 0.70, and Gwet’s AC 0.93. This level of concordance is comparable to those reported in other pathology studies [49–52].
Median total histology scores of the Zambian and Pakistani WSIs fell between those of the control and GSE cohorts (Fig 1 and Table 5; all p-values FDR-adjusted within tests). St. Louis control, Zambian, and Pakistani WSI total histology score percent distributions significantly differed from that of the GSE WSIs (p ≤0.0001, 0.02, and 0.0005, respectively). The distribution of Zambian WSI total score percent differed from those of the non-GSE controls (p = 0.01), while Pakistani WSI score percent did not (p = 0.20). Score percent distributions for Pakistani and Zambian WSIs did not differ significantly (p = 0.13).
Compared to the St. Louis GSE cohort, the St. Louis control, Pakistani and Zambian cohorts had lower total histology scores (p<0.0001, p = 0.0005, and p = 0.02, respectively). Total histology score percent did not differ significantly between the Pakistani and Zambian WSIs (p = 0.13). Statistical analysis was performed by Kruskal-Wallis test followed by Dunn’s multiple comparisons test with Benjamini-Hochberg correction for false discovery error rate. *: p ≤ 0.05; **: p ≤ 0.01; ****: p ≤ 0.0001. The bars indicate mean ± standard deviation.
Fig 2 (and S2 Table) show the individual histology features for each cohort. Several patterns are discernible. Compared to the GSE WSIs, the Zambian and Pakistani WSIs had less chronic inflammatory infiltration of the lamina propria (Fig 2A), and lower abundances of intramucosal Brunner glands (Fig 2B). However, the Pakistani cohort had markedly increased IELs, with densities similar to those of the GSE cohort (Fig 2C). In contrast, the Zambian cohort had notably fewer secretory lineage cells (goblet and Paneth cells; Fig 2D and 2E), more enterocyte injury (Fig 2F), a tendency toward epithelial detachment (Fig 2G) and more severe villous architectural damage (Fig 2H). There were no substantial neutrophilic inflammation, eosinophilic infiltration, or foveolar metaplasia in tissue from any cohort (S2 Fig). Pathogens were only observed in the Pakistani cohort and limited to Giardia in five of 10 children’s slide images (two of whom had Giardia detected in all of the WSI).
The GSE cohort had the highest scores in the categories of (A) chronic inflammation and (B) intramucosal Brunner’s gland. Between the Pakistani and Zambian cohorts, the Pakistani cohort had (C) more intraepithelial lymphocytes. In contrast, the Zambian cohort had higher scores in the categories of (D) goblet cell density, (E) Paneth cell density, (F) enterocyte injury, and (G) epithelial detachment. The Zambian cohort also tended to have higher scores in (H) villous architecture derangement. Sample size: Pakistani n = 10, Zambian n = 16, GSE n = 13, control n = 6. *: p ≤ 0.05; **: p ≤ 0.01; ***: p ≤ 0.001; ****: p ≤ 0.0001. Statistical analysis was performed by Kruskal-Wallis test followed by Dunn’s multiple comparisons test and corrected within tests for false discovery rate by the Benjamini-Hochberg method. The bars indicate mean ± standard deviation.
Heterogeneity of pathology findings in the Pakistani cohort
A distinguishing feature of the Pakistani study design is that each biopsy was allocated to single slides, thereby yielding multiple distinct WSIs per child for analysis of lesion patchiness. As seen in Fig 3A, the maximal discrepancy between different biopsies from the same patient could generate a difference in total histologic percent score of ~5. Individual histologic features that tended to differ by ≥2 levels of pathology between biopsies from the same child include villous architecture (Fig 3B) and the presence of intramucosal Brunner glands (Fig 3C). In contrast, IEL, goblet cell and Paneth cell densities as well as chronic lamina propria inflammation were often only 1–2 levels apart between different biopsy specimens from an individual (S3 Fig). Estimates of intra-class correlation from a multilevel model indicated that within-child variation exceeded between-child variation for total histologic score percent (57.4% vs. 42.6%, respectively, p = 0.013).
The scores for each individual biopsy for each subject were plotted for (A) total EED histology score percent, (B) villous architecture, and (C) intramucosal Brunner glands as these showed the highest variability between biopsies. The bars indicate mean ± standard deviation.
To determine if the reading of individual versus multiple biopsies may have affected the scoring reproducibility by the study pathologists, we took advantage of their assessment of the number of tissue fragments on each WSI. The cohort was divided into two sets, one in which the average number of tissue fragments was one (n = 15) and the other in which the average was >1 (n = 46). The degree of agreement between the pathologists for the histologic parameters was approximately the same (Table 6 and S2 Dataset), indicating that the number of tissue fragments being assessed by the pathologists did not significantly contribute to the degree of histologic agreement.
Association of histology scores to patient characteristics
We next determined if the histology scores correlated with clinical characteristics. HIV infection status in the Zambia cohort was not associated with total histology percent score or any individual histology parameter scores. After adjusting for site, total histologic score percent and the histology parameter scores were not significantly associated with HAZ, or WHZ in the combined study cohort. The only site-specific associations were identified in the Pakistani cohort, for which IEL density was inversely associated with all three anthropometric parameters: HAZ (ß = -1.1, 95% CI -1.8, -0.5; p = 0.004), WAZ (ß = -1.1, CI -2.1, -0.1; p = 0.03), and WHZ (ß = -0.8, CI -1.4, -0.2; p = 0.01). Also, in this cohort an unexpected positive association was observed between villous architecture score and LAZ (ß = 1.2, CI 0.4, 2.0; p = 0.008).
Adjusting for cohort, clinical laboratory and EED or growth biomarkers were similarly not significantly associated with histology total score percent or subscores, with one exception: IGF-1, measured in the EED cohorts only, was borderline associated with Paneth cell density (ß = -8.0, CI-15.7, -0.4; p = 0.04). No associations were found between histologic scores and lactulose: mannitol ratios (not performed in the Pakistani cohort, and half of the GSE and control subjects were tested for lactulose: rhamnose ratio), hemoglobin concentrations, MCV, CRP, tTG IgA (expressed as a percent of upper limit of normal) or GLP-2 concentrations. Several marginally significant relationships between histology scores and patient characteristics of small effect sizes were observed (S3 Table).
Patterns of histologic changes in the gut have long been associated with both specific diarrheal and malabsorptive entities, as well as non-specific reactive/adaptive changes to injury. This includes histologic features that have been identified among individuals from indigenous populations and from travelers spending time in “tropical” areas that have experienced chronic malabsorption syndromes, so-called “tropical sprue” . Similar histologic changes have been noted in asymptomatic individuals in the same geographic areas, so-called” “tropical enteropathy”, now referred to as environmental enteropathy or as EED [10, 54]. Among the issues that have hampered identification and subclassification of EED and the discovery of its underlying etiologies has been the lack of a robust and systematic method of categorizing and quantifying the intestinal histologic changes from cohorts of affected individuals.
To address this shortcoming in the field, we developed a histology index specific for duodenal biopsies that queries several distinct histologic parameters including quantity and type of various inflammatory cells and several epithelial differentiation lineage cells, mucosal architectural features, and epithelial cell injury patterns. Each parameter was given a numerical range of severity, with each numerical grade specifically defined. While the reproducibility between the three gastrointestinal pathologists in this study for grading the individual parameters varied, the overall score reproducibility was in the same range of interobserver reproducibility described for other accepted histology indices (overall kappa coefficient of 0.70), including those for grading inflammatory changes in ulcerative colitis (37) and due to H. pylori . Thus, the performance of the histology index described here appears to conform to the general performance of histologic assessment of tissue pathology and is suitable for use in comparing cohorts with enteropathies, including EED. IELs, chronic inflammation, and villous architecture were the parameters with the lowest inter-pathologist concordance. Inflammatory markers may be better assessed by special stains, such as immunohistochemistry. Villous architecture scores also had the widest range, compared to all other parameters. Quantitative morphometry may offer more precision in characterizing this feature, but such measurements are also labor intensive and require good tissue orientation on the slide. Future work should assess whether morphometry provides substantial gains in precision compared to subjective pathologist assessments “by eye”.
Our data offer provisional guidance regarding the numbers of biopsies to be obtained when attempting to identify EED. Most notably, we found no significant difference in the overall concordance between pathologists for the histologic parameters based on the reading of a single tissue fragment (Pakistani), or multiple tissue fragments to generate a composite score from the tissue on the slide (Zambian). However, the Pakistani biopsies, apportioned into separate cassettes, demonstrate considerable within-host (i.e., inter-biopsy) variability. Specifically, the degree of discordance of overall histologic scores was greater between biopsies of the same child than between those of different children in the Pakistani cohort. The greatest intra-individual variability related to the assessment of intramucosal Brunner glands, which are known to have a focal and nodular appearance when increased in the duodenum . Because of its patchy nature, EED mucosal biopsy studies should include multiple biopsies, but pieces obtained can be considered as a pooled specimen set, to reduce the possibility of missing a case, to more comprehensively assess affected tissue, and to reduce analytic variability from sampling bias. This is standard endoscopic biopsy practice for diagnosing GSE [55, 56].
Our data demonstrate similarities and differences between the cohorts that warrant comment. While EED and GSE cohorts share histopathologic similarities, as suggested by prior studies [26, 40, 57–60], our index showed differences in the main histologic features that are classically associated with GSE, including intraepithelial lymphocytes. We also had the opportunity to compare a GSE case from Pakistan (excluded from this analysis) whose total histologic score was somewhat less severe than the median scores of the St. Louis GSE cohort, although overall showed a similar pattern of tissue injury (detailed comparison of scores to St. Louis GSE and Pakistani cohorts in S4 Table). A single case does not permit generalizations about the overlap between EED and GSE pathology, but raises the possibility that GSE disease may be distinguishable from EED by histopathology, as has been suggested in previous literature as well [26, 40, 57, 59, 60]. This may be most important in settings where both enteropathies co-exist.
There are several limitations of this current dataset. Due to ethical concerns, controls from EED endemic settings could not be included as endoscopic biopsies are invasive procedures that cannot be performed on otherwise healthy young children and clinical biopsies for non-enteropathy indications are quite rare at those sites. Along this line, while there were suggestions of cohort-specific histology features, we cannot exclude with certainty that the Zambian cohort findings are due to younger age, higher severity of the same enteropathy (namely EED), and/or contributions of a severe acute malnutrition-induced enteropathy. We attempted to perform an exploratory analysis of histopathology scores and patient characteristics but were hampered by samples sizes insufficient to detect significant associations. Such an analysis should be repeated with sufficiently powered data to test hypothesis driven approaches, and confirm or refute our findings, including those that were paradoxical (i.e., intramucosal Brunner gland density and villous architecture derangements with anthropometric Z scores) or not significant. EED might not be a globally applicable single entity. For example, there are differences between the intestinal lesions in the Pakistani and Zambian cohorts that we cannot readily explain, and might reflect genetics, environment, or the different indications for the endoscopic biopsies. Nonetheless, small bowel dysfunction appears to be a common finding in malnourished children in LMICs, and this report adds histologic data to recent attempts to better define EED for diagnostic and therapeutic purposes [9, 61]. Finally, it is also possible that as future data emerge regarding the causes and consequences of the histopathologic lesions we report and the concomitant clinical phenotypes, the entity we describe as EED might be superseded by new terminology. Nosologic reconsiderations might assign EED to be a specific enteropathy subtype, or EED itself might be subjected to its own variants.
It will be important to determine if the initial findings reported here extend to a larger and more diverse cohort of patients with EED. This scoring index is currently being applied to the approximately 550 biopsies by an expanded study team across five diverse sites: Zambia, Pakistan, Bangladesh and two North American comparison sites. This robust application will allow for refinement of the scoring system. This could include elimination of parameters that continue to demonstrate low performance in detection of EED and construction of a weighted algorithm of the index to more accurately define EED (e.g., certain parameters carry more weight toward the final score than others).
In summary, we described the development and validation of a new tool in the investigation of EED: a histology index designed for the study of small intestinal biopsies. The histology index can be used reproducibly by histopathologists to create parameter specific as well as overall pathology scores to compare to clinical and laboratory attributes in EED cohorts. The adoption of this index will aid not only in comparison of data within studies but in the comparison of data from separate studies. Given the durability of histologic specimens, there is an opportunity for this index to be used on archival samples from previous studies to provide historical comparison of cohorts in addition to those of contemporaneous and prospective studies. Perhaps most importantly, because the EED histopathology scoring index includes specific parameters indicative of injury processes, the system can be applied to identify histopathologic processes that distinguish EED from other enteropathies and to inform novel intervention targets and assess response to interventions.
S1 Table. Spearman correlation of total histologic score percent by pathologist pair.
S2 Table. Median, IQR, and range of histology scores by cohort.
S3 Table. Marginal associations with minimal effect sizes for regression analyses of histology score parameters with patient characteristics.
S4 Table. Histology scores of Pakistan GSE case compared to Pakistan & St. Louis GSE cohorts histology score medians.
S1 Atlas. Duodenal histopathology grading scheme used in this study.
S2 Dataset. Histopathology concordance dataset in this study.
S1 Fig. Clinical parameters, Zambian and Pakistani cohorts.
Due to differences in study design, the subjects in the Zambian cohort were (A) younger (p = 0.0012), (B) had diarrhea histories of longer durations (p < 0.0001), and (C) had borderline lower WHZ score (p = 0.047), Hemoglobin concentrations were marginally lower in the Zambia cohort (p = 0.062) and there was no difference in tTG antibody circulating concentrations (as a percent of upper limit of normal, p = 0.16). Statistical analysis was performed by Mann-Whitney tests.
S2 Fig. Scores of individual histology features between cohorts.
None of these cohorts had significant differences in (A) neutrophilic inflammation, (B) eosinophilic infiltration, and (C) foveolar metaplasia. Sample size: Pakistani n = 10, Zambian n = 16, GSE n = 13, control n = 6.
S3 Fig. Individual histology heterogeneity in the Pakistani cohort.
The scores for each individual biopsy for each subject were plotted for (A) intraepithelial lymphocytes density, (B) goblet cell density, (C) Paneth cell density, and (D) chronic inflammation. These parameters showed some within-child variation, but less than the scores for villous architecture and intramucosal Brunner glands.
- 1. Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, et al. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet. 2013;382(9890):427–51. pmid:23746772.
- 2. Levels and trends in child malnutrition: UNICEF/WHO/World Bank Group Joint Child Malnutrition Estimates Key findings of the 2019 edition Geneva: World Health Organization; 2019.
- 3. Trowell HC, Muwazi EM. Severe and prolonged underfeeding in African children: (The Kwashiorkor Syndrome of Malignant Malnutrition). Archives of disease in childhood. 1945;20(103):110–6. pmid:21032306; PubMed Central PMCID: PMC1987968.
- 4. Bhutta ZA, Berkley JA, Bandsma RHJ, Kerac M, Trehan I, Briend A. Severe childhood malnutrition. Nat Rev Dis Primers. 2017;3:17067. pmid:28933421.
- 5. Dewey KG, Adu-Afarwuah S. Systematic review of the efficacy and effectiveness of complementary feeding interventions in developing countries. Matern Child Nutr. 2008;4 Suppl 1:24–85. pmid:18289157.
- 6. Dewey KG. Reducing stunting by improving maternal, infant and young child nutrition in regions such as South Asia: evidence, challenges and opportunities. Matern Child Nutr. 2016;12 Suppl 1:27–38. pmid:27187908; PubMed Central PMCID: PMC5084734.
- 7. Tofail F, Fernald LC, Das KK, Rahman M, Ahmed T, Jannat KK, et al. Effect of water quality, sanitation, hand washing, and nutritional interventions on child development in rural Bangladesh (WASH Benefits Bangladesh): a cluster-randomised controlled trial. Lancet Child Adolesc Health. 2018;2(4):255–68. pmid:29616235; PubMed Central PMCID: PMC5859216.
- 8. Stewart CP, Kariger P, Fernald L, Pickering AJ, Arnold CD, Arnold BF, et al. Effects of water quality, sanitation, handwashing, and nutritional interventions on child development in rural Kenya (WASH Benefits Kenya): a cluster-randomised controlled trial. Lancet Child Adolesc Health. 2018;2(4):269–80. pmid:29616236; PubMed Central PMCID: PMC5859215.
- 9. Keusch GT, Denno DM, Black RE, Duggan C, Guerrant RL, Lavery JV, et al. Environmental enteric dysfunction: pathogenesis, diagnosis, and clinical consequences. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2014;59 Suppl 4:S207–12. pmid:25305288; PubMed Central PMCID: PMC4481570.
- 10. Korpe PS, Petri WA Jr. Environmental enteropathy: critical implications of a poorly understood condition. Trends in molecular medicine. 2012;18(6):328–36. pmid:22633998; PubMed Central PMCID: PMC3372657.
- 11. Owino V, Ahmed T, Freemark M, Kelly P, Loy A, Manary M, et al. Environmental Enteric Dysfunction and Growth Failure/Stunting in Global Child Health. Pediatrics. 2016;138(6). pmid:27940670.
- 12. Harper KM, Mutasa M, Prendergast AJ, Humphrey J, Manges AR. Environmental enteric dysfunction pathways and child stunting: A systematic review. PLoS neglected tropical diseases. 2018;12(1):e0006205. pmid:29351288; PubMed Central PMCID: PMC5792022.
- 13. Denno DM, VanBuskirk KM, Nelson ZC, Musser CA, Tarr PI. Environmental enteric dysfunction: Advancing current knowledge. Saint Louis, MO: Washington University Libraries2016.
- 14. Lin A, Arnold BF, Afreen S, Goto R, Huda TM, Haque R, et al. Household environmental conditions are associated with enteropathy and impaired growth in rural Bangladesh. Am J Trop Med Hyg. 2013;89(1):130–7. pmid:23629931; PubMed Central PMCID: PMC3748469.
- 15. Hossain MI, Nahar B, Hamadani JD, Ahmed T, Roy AK, Brown KH. Intestinal mucosal permeability of severely underweight and nonmalnourished Bangladeshi children and effects of nutritional rehabilitation. Journal of pediatric gastroenterology and nutrition. 2010;51(5):638–44. pmid:20871416; PubMed Central PMCID: PMC3020319.
- 16. Naylor C, Lu M, Haque R, Mondal D, Buonomo E, Nayak U, et al. Environmental Enteropathy, Oral Vaccine Failure and Growth Faltering in Infants in Bangladesh. EBioMedicine. 2015;2(11):1759–66. pmid:26870801; PubMed Central PMCID: PMC4740306.
- 17. Kosek M, Haque R, Lima A, Babji S, Shrestha S, Qureshi S, et al. Fecal markers of intestinal inflammation and permeability associated with the subsequent acquisition of linear growth deficits in infants. Am J Trop Med Hyg. 2013;88(2):390–6. pmid:23185075; PubMed Central PMCID: PMC3583335.
- 18. Panter-Brick C, Lunn PG, Langford RM, Maharjan M, Manandhar DS. Pathways leading to early growth faltering: an investigation into the importance of mucosal damage and immunostimulation in different socio-economic groups in Nepal. The British journal of nutrition. 2009;101(4):558–67. pmid:18662426.
- 19. Lindenbaum J, Kent TH, Sprinz H. Malabsorption and jejunitis in American Peace Corps volunteers in Pakistan. Annals of internal medicine. 1966;65(6):1201–9. PubMed pmid:5928480.
- 20. Lindenbaum J, Gerson CD, Kent TH. Recovery of small-intestinal structure and function after residence in the tropics. I. Studies in Peace Corps volunteers. Annals of internal medicine. 1971;74(2):218–22. PubMed pmid:5545229.
- 21. Keusch GT, Plaut AG, Troncale FJ. Subclinical malabsorption in Thailand. II. Intestinal absorption in American military and Peace Corps personnel. Am J Clin Nutr. 1972;25(10):1067–79. pmid:5078331.
- 22. Lindenbaum J, Alam AK, Kent TH. Subclinical small-intestinal disease in East Pakistan. Br Med J. 1966;2(5530):1616–9. PubMed pmid:5926127; PubMed Central PMCID: PMC1944476.
- 23. Marie C, Ali A, Chandwe K, Petri WA Jr., Kelly P. Pathophysiology of environmental enteric dysfunction and its impact on oral vaccine efficacy. Mucosal immunology. 2018;11(5):1290–8. pmid:29988114.
- 24. Schneider RE, Viteri FE. Morphological aspects of the duodenojejunal mucosa in protein—calorie malnourished children and during recovery. Am J Clin Nutr. 1972;25(10):1092–102. pmid:4627874.
- 25. Fagundes-Neto U, Viaro T, Wehba J, Patricio FR, Machado NL. Tropical enteropathy (environmental enteropathy) in early childhood: a syndrome caused by contaminated environment. J Trop Pediatr. 1984;30(4):204–9. pmid:6492234.
- 26. Sullivan PB, Marsh MN, Mirakian R, Hill SM, Milla PJ, Neale G. Chronic diarrhea and malnutrition—histology of the small intestinal lesion. Journal of pediatric gastroenterology and nutrition. 1991;12(2):195–203. PubMed pmid:1904932.
- 27. Sullivan PB, Lunn PG, Northrop-Clewes C, Crowe PT, Marsh MN, Neale G. Persistent diarrhea and malnutrition—the impact of treatment on small bowel structure and permeability. Journal of pediatric gastroenterology and nutrition. 1992;14(2):208–15. PubMed pmid:1593377.
- 28. Sullivan PB. Studies of the small intestine in persistent diarrhea and malnutrition: the Gambian experience. Journal of pediatric gastroenterology and nutrition. 2002;34 Suppl 1:S11–3. PubMed pmid:12082380.
- 29. Ordiz MI, Shaikh N, Trehan I, Maleta K, Stauber J, Shulman R, et al. Environmental Enteric Dysfunction Is Associated With Poor Linear Growth and Can Be Identified by Host Fecal mRNAs. Journal of pediatric gastroenterology and nutrition. 2016;63(5):453–9. pmid:27347722; PubMed Central PMCID: PMC5084633 is also supported by the NIH Biobank Core of the Washington University DDRCC (P30DK052574). The sponsors played no role in the study design, data collection, data analyses, interpretation, or decision to submit for publication. P.I.T. is a co-inventor of a new method to detect increased gut permeability. The remaining authors report no conflicts of interest.
- 30. Kosek MN, Investigators M- EN. Causal Pathways from Enteropathogens to Environmental Enteropathy: Findings from the MAL-ED Birth Cohort Study. EBioMedicine. 2017;18:109–17. pmid:28396264; PubMed Central PMCID: PMC5405169.
- 31. Guerrant RL, Leite AM, Pinkerton R, Medeiros PH, Cavalcante PA, DeBoer M, et al. Biomarkers of Environmental Enteropathy, Inflammation, Stunting, and Impaired Growth in Children in Northeast Brazil. PloS one. 2016;11(9):e0158772. pmid:27690129; PubMed Central PMCID: PMC5045163.
- 32. Iqbal NT, Sadiq K, Syed S, Akhund T, Umrani F, Ahmed S, et al. Promising Biomarkers of Environmental Enteric Dysfunction: A Prospective Cohort study in Pakistani Children. Scientific reports. 2018;8(1):2966. pmid:29445110; PubMed Central PMCID: PMC5813024.
- 33. Lebwohl B, Sanders DS, Green PHR. Coeliac disease. Lancet. 2018;391(10115):70–81. pmid:28760445.
- 34. Campbell DI, Murch SH, Elia M, Sullivan PB, Sanyang MS, Jobarteh B, et al. Chronic T cell-mediated enteropathy in rural west African children: relationship with nutritional status and small bowel function. Pediatric research. 2003;54(3):306–11. pmid:12788978.
- 35. Stanfield JP, Hutt MS, Tunnicliffe R. Intestinal biopsy in kwashiorkor. Lancet. 1965;2(7411):519–23. PubMed pmid:4158176.
- 36. Amadi B, Fagbemi AO, Kelly P, Mwiya M, Torrente F, Salvestrini C, et al. Reduced production of sulfated glycosaminoglycans occurs in Zambian children with kwashiorkor but not marasmus. Am J Clin Nutr. 2009;89(2):592–600. pmid:19116330.
- 37. Attia S, Feenstra M, Swain N, Cuesta M, Bandsma RHJ. Starved Guts: Morphologic and Functional Intestinal Changes in Malnutrition. Journal of pediatric gastroenterology and nutrition. 2017;65(5):491–5. pmid:28489672.
- 38. Burman D. The jejunal mucosa in kwashiorkor. Archives of disease in childhood. 1965;40(213):526–31. PubMed pmid:5829998; PubMed Central PMCID: PMC2019458.
- 39. Amadi B, Besa E, Zyambo K, Kaonga P, Louis-Auguste J, Chandwe K, et al. Impaired Barrier Function and Autoantibody Generation in Malnutrition Enteropathy in Zambia. EBioMedicine. 2017;22:191–9. pmid:28750860; PubMed Central PMCID: PMC5552244.
- 40. Syed S, Yeruva S, Herrmann J, Sailer A, Sadiq K, Iqbal N, et al. Environmental Enteropathy in Undernourished Pakistani Children: Clinical and Histomorphometric Analyses. Am J Trop Med Hyg. 2018;98(6):1577–84. pmid:29611507; PubMed Central PMCID: PMC6086170.
- 41. Faubion WA, Camilleri M, Murray JA, Kelly P, Amadi B, Kosek MN, et al. Improving the detection of environmental enteric dysfunction: a lactulose, rhamnose assay of intestinal permeability in children aged under 5 years exposed to poor sanitation and hygiene. BMJ Glob Health. 2016;1(1):e000066. pmid:28588929; PubMed Central PMCID: PMC5321325.
- 42. Hill ID, Fasano A, Guandalini S, Hoffenberg E, Levy J, Reilly N, et al. NASPGHAN Clinical Report on the Diagnosis and Treatment of Gluten-related Disorders. Journal of pediatric gastroenterology and nutrition. 2016;63(1):156–65. pmid:27035374.
- 43. Marsh JN, Matlock MK, Kudose S, Liu TC, Stappenbeck TS, Gaut JP, et al. Deep Learning Global Glomerulosclerosis in Transplant Kidney Frozen Sections. IEEE Trans Med Imaging. 2018;37(12):2718–28. pmid:29994669; PubMed Central PMCID: PMC6296264.
- 44. Pantanowitz L, Valenstein PN, Evans AJ, Kaplan KJ, Pfeifer JD, Wilbur DC, et al. Review of the current state of whole slide imaging in pathology. J Pathol Inform. 2011;2:36. pmid:21886892; PubMed Central PMCID: PMC3162745.
- 45. Surgical pathology of the GI tract, liver, biliary tract and pancreas, 3rd edition. Odze R, Goldblum JR, editors2015.
- 46. WHO Child Growth Standards: Length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: Methods and development. [Internet]. World Health Organization. 2006.
- 47. WHO Anthro for personal computers, version 3.2.2, 2011: Software for assessing growth and development of the world's children. Geneva: WHO; 2010.
- 48. Software for assessing growth of the world's children and adolescents. 1.0.4 ed. Geneva: World Health Organization; 2009.
- 49. Mosli MH, Feagan BG, Zou G, Sandborn WJ, D'Haens G, Khanna R, et al. Reproducibility of histological assessments of disease activity in UC. Gut. 2015;64(11):1765–73. pmid:25360036.
- 50. Mendler MH, Kanel G, Govindarajan S. Proposal for a histological scoring and grading system for non-alcoholic fatty liver disease. Liver Int. 2005;25(2):294–304. pmid:15780053.
- 51. Talreja JP, Sethi A, Jamidar PA, Singh SK, Kwon RS, Siddiqui UD, et al. Interpretation of probe-based confocal laser endomicroscopy of indeterminate biliary strictures: is there any interobserver agreement? Digestive diseases and sciences. 2012;57(12):3299–302. pmid:22875310.
- 52. Andrew A, Wyatt JI, Dixon MF. Observer variation in the assessment of chronic gastritis according to the Sydney system. Histopathology. 1994;25(4):317–22. PubMed pmid:7835836.
- 53. Alvarez JJ, Zaga-Galante J, Vergara-Suarez A, Randall CW. Tropical Sprue. Journal of Tropical Diseases and Public Health. 2014;2:1000130.
- 54. Louis-Auguste J, Kelly P. Tropical Enteropathies. Current gastroenterology reports. 2017;19(7):29. pmid:28540669; PubMed Central PMCID: PMC5443857.
- 55. Rashid M, MacDonald A. Importance of duodenal bulb biopsies in children for diagnosis of celiac disease in clinical practice. BMC gastroenterology. 2009;9:78. pmid:19835611; PubMed Central PMCID: PMC2771033.
- 56. Ravelli A, Villanacci V, Monfredini C, Martinazzi S, Grassi V, Manenti S. How patchy is patchy villous atrophy?: distribution pattern of histological lesions in the duodenum of children with celiac disease. The American journal of gastroenterology. 2010;105(9):2103–10. pmid:20372112.
- 57. Syed S, Al-Boni M, Khan MN, Sadiq K, Iqbal NT, Moskaluk CA, et al. Assessment of Machine Learning Detection of Environmental Enteropathy and Celiac Disease in Children. JAMA Netw Open. 2019;2(6):e195822. pmid:31199451.
- 58. Syed S, Dinallo V, Iqbal NT, Di Iorio L, Di Fusco D, Guleria S, et al. High SMAD7 and p-SMAD2,3 expression is associated with environmental enteropathy in children. PLoS neglected tropical diseases. 2018;12(2):e0006224. pmid:29415065; PubMed Central PMCID: PMC5819826.
- 59. Schenk EA, Samloff IM, Klipstein FA. Morphologic characteristics of jejunal biopsy in celiac disease and tropical sprue. The American journal of pathology. 1965;47(5):765–81. pmid:5843417; PubMed Central PMCID: PMC1920473.
- 60. Brown IS, Bettington A, Bettington M, Rosty C. Tropical sprue: revisiting an underrecognized disease. The American journal of surgical pathology. 2014;38(5):666–72. pmid:24441659.
- 61. Denno DM, Tarr PI, Nataro JP. Environmental Enteric Dysfunction: A Case Definition for Intervention Trials. Am J Trop Med Hyg. 2017;97(6):1643–6. pmid:29016294; PubMed Central PMCID: PMC5805039.